MD ANDERSON
LIVE

Serial Number

98480259

Owner

The Board of Regents of The University of Texas System

Attorney

Robin Lightner Maisashvili

First Use Date

Jan 1, 1942

Filing Date

Apr 2, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MD ANDERSON Trademark

Serial Number: 98480259 • Registration: 7896459

MD ANDERSON is a trademark filed by The Board of Regents of The University of Texas System on April 2, 2024. The trademark is classified under Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

The Board of Regents of The University of Texas System (257 trademarks)

201 West 7th Street
Austin, TX 78701

Entity Type: 14

Trademark Details

Filing Date

April 2, 2024

Registration Date

August 19, 2025

First Use Anywhere

January 1, 1942

First Use in Commerce

January 1, 1942

Published for Opposition

June 3, 2025

Goods & Services

Business consulting on the establishment, management, and operation of cancer treatment centers; promoting collaboration within the scientific and medical communities to achieve advances in healthcare; promoting public awareness of cancer, cancer research, cancer prevention and cancer treatment

Providing patient advocate services in the treatment of diseases and disorders; providing a website featuring supportive personal stories on the subjects of health and cancer; providing personal support services for patients and families of patients with cancer, namely, emotional counseling and emotional support

Medical services; medical services, namely, cellular immunotherapy treatments; medical services, namely, human cancer treatment; providing medical information relating to immunotherapy; providing medical advice and consultancy regarding cancer therapies; medical and pharmaceutical consultation; medical services relating to cancer; dispensing of pharmaceuticals relating to cancer; immunobiology and immunotherapy medical services; medical services, namely, the treatment of cancer; medical consulting services, namely, consulting on the treatment of cancer; providing health information in the field of oncology, immunobiology, immunotherapy, and diseases; providing a web site featuring medical and health information; providing medical information, consultancy and advisory services; providing medical information relating to pharmaceuticals; providing information on health care via a telephone and the internet; providing information on cancer treatment; medical analysis services, namely, analysis of tumors, cancer and related medical conditions

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 19, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 19, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 3, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 3, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 28, 2025 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 6, 2025 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 9, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 9, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 9, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 9, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 9, 2025 CNEA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 17, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 17, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 17, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 17, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 17, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 15, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 7, 2024 NWOS
NEW APPLICATION ENTERED
Apr 2, 2024 NWAP